Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes

Diabetic Medicine

Volumn 29, Issue 8, 2012, Pages 990-994

  Theilade, S ^a   Lajer, M ^a   Jorsal, A ^a   Tarnow, L ^a   Parving, H H ^b,c   Rossing, P ^a  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Cardiovascular disease; Kidney disease; Placental growth factor; Pulse pressure; Type 1 diabetes; Vascular

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; PLACENTAL GROWTH FACTOR;

ADULT; ALBUMIN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PULSE PRESSURE; SMOKING;

ADULT; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREGNANCY PROTEINS; PROSPECTIVE STUDIES; VASCULAR STIFFNESS;

EID: 84863996228     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03633.x     Document Type: Article

References (28)

1. Triantafyllidi H, Tzortzis S, Lekakis J, Ikonomidis I, Arvaniti C, Trivilou P et al. Association of target organ damage with three arterial stiffness indexes according to blood pressure dipping status in untreated hypertensive patients. Am J Hypertens 2010; 23: 1265-1272.
2. Schram MT, Kostense PJ, van Dijk RA, Dekker JM, Nijpels G, Bouter LM et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens 2002; 20: 1743-1751.
3. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 1999; 100: 354-360.
4. Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC et al. Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol 2003; 41: 1753-1758.
5. Lee KW, Blann AD, Lip GY. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 2005; 18: 104-115.
6. Beigel R, Dvir D, Arbel Y, Shechter A, Feinberg MS, Shechter M. Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease. Vasc Med 2010; 15: 299-305.
7. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De MM et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575-583.
8. Pilarczyk K, Sattler KJ, Galili O, Versari D, Olson ML, Meyer FB et al. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 2008; 196: 333-340.
9. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-564.
10. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 2002; 15: 244-250.
11. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH. Relationship between risk factors and mortality in Type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31: 1360-1366.
12. Gordin D, Waden J, Forsblom C, Thorn L, Rosengard-Barlund M, Tolonen N et al. Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with Type 1 diabetes (The FinnDiane Study). Diabetes Care 2011; 34: 886-891.
13. Schram MT, Chaturvedi N, Fuller JH, Stehouwer CD. Pulse pressure is associated with age and cardiovascular disease in Type 1 diabetes: the Eurodiab Prospective Complications Study. J Hypertens 2003; 21: 2035-2044.
14. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH et al. Markers of endothelial dysfunction and inflammation in Type 1 diabetic patients with or without diabetic nephropathy followed for 10years: association with mortality and decline of glomerular filtration rate. Diabetes Care 2008; 31: 1170-1176.
15. Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy. Diabet Med 2012; 29: 337-344.
16. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.
17. Safar ME, Blacher J, Jankowski P. Arterial stiffness, pulse pressure, and cardiovascular disease - is it possible to break the vicious circle? Atherosclerosis 2011; 218: 263-271.
18. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759-766.
19. Rognant N, Lemoine S, Laville M, Hadj-Aissa A, Dubourg L. Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients. Diabetes Care 2011; 34: 1320-1322.
20. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-988.
21. Palmas W, Pickering T, Eimicke JP, Moran A, Teresi J, Schwartz JE et al. Value of ambulatory arterial stiffness index and 24-h pulse pressure to predict progression of albuminuria in elderly people with diabetes mellitus. Am J Hypertens 2007; 20: 493-500.
22. Lovett JK, Howard SC, Rothwell PM. Pulse pressure is independently associated with carotid plaque ulceration. J Hypertens 2003; 21: 1669-1676.
23. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 2008; 105: 1652-1660.
24. Laurent S, Cockcroft J, Van BL, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
25. Trika CO, Zakopoulos N, Toumanidis ST, Stamatelopoulos SF, Moulopoulos SD. Pulse pressure and left ventricular diastolic dysfunction in hypertensive patients. Cardiology 2004; 102: 108-114.
26. Khurana R, Moons L, Shafi S, Luttun A, Collen D, Martin JF et al. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 2005; 111: 2828-2836.
27. Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 2005; 18: 3S-10S.
28. Law LW, Sahota DS, Chan LW, Chen M, Lau TK, Leung TY. Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Matern Fetal Neonatal Med 2010; 23: 1475-1480.